Mina M. Rizk, MD
a:1:{i:0;s:368:"Department of Psychiatry, Icahn School of Medicine at Mount Sinai, New York, New York, Molecular Imaging and Neuropathology Division, New York State Psychiatric Institute, New York
Narrative Review
Immune Targeted Therapies for Depression: Antidepressant Effects of Monoclonal Antibodies
June 24, 2024
Immune dysregulation may contribute to treatment resistance in depression. Monoclonal antibodies have shown promise in treating depression when used for inflammatory disorders and may offer new hope for patients...
